Perutz's discovery that heavy atom labeling can give Cell Press phase information for solving protein crystal structures. For DNA biology, after the double helix itself came the genetic code, the "central dogma," semi-conservative Meetings held in late April to mark the 50 th anniversary replication, sequencing, and of course the vast array of of the elucidation of the DNA double helix covered the subjects and technologies that come under the umbrella past, present, and future of DNA biology. of molecular biology. Mere words seem rather inadequate to express the impact that these advances have Even in their wildest dreams, it seems unlikely that back had on science as we now know it. The Royal Society in 1953 Watson and Crick could have imagined how far meeting in London showcased the current status of DNA DNA science would develop in 50 years. We've come research. David Sherratt and Steve West organized a all the way from their initial description of the structure two-day program that covered DNA replication, recomof DNA to the announcement of a refined and almost bination, and repair, and related topics such as chromocomplete human genome sequence, with many landsome structure and genetic instability during tumorigenmarks in between. For most of us, molecular biology esis. Taken together, these presentations provided a and genomics are so integrated into our scientific psydramatic illustration of how far the DNA biology field che that we rarely stop to think how remarkable these has progressed. At this point, not only do we have a achievements are. The "DNA 50" anniversary gave us substantial amount of information about how DNA is an opportunity to do so, and also to think about how manipulated and maintained, we also are beginning to biology will move forward in the post-genomic era. analysis of genomic and gene expression data is improvenough to be able to attend these events were treated ing continuously. A realistic goal for the near future is to a mixture of historical accounts, reminiscences, and to use cross-species genome sequence comparisons modern science. The great and the good gathered for to help with delineating coding genes and, perhaps more the science and the socializing, including gala dinners importantly, in understanding the functions and regulain New York, London, and Cambridge. tory significance of non-coding regions. Existing seNot surprisingly, much of the historical discussion at quences are already providing insights along these lines, the meetings, and in the myriad of journal and newspaand in Cambridge John Sulston and Gerry Rubin gave per articles that have also appeared, focused on what updates about the history and current status of genome happened in 1953. We learned about the circumstances projects from different organisms, including Drosophila, that brought Watson and Crick together, the synergy C. elegans, and humans. We look forward to the day they developed, and the contributions they both made.
quenced in parallel, to form a resource for this type of research. This may seem a daunting task, but if we consider the progress of the past 50 years, perhaps it isn't such an unrealistic goal.
Aside from the basic biological interest in understanding human variation, there are also more practical benefits. Genomic information, combined with gene expression analysis, could be used to target therapies to patients most likely to benefit from them and to avoid treating those likely to suffer from adverse side effects. In his presentation in Cambridge, George Poste covered several issues related to health care applications. He discussed how such strategies are already being developed in the treatment of some diseases, such as HIV, and how they have the potential to become much more widespread. Harold Varmus also outlined the ways in which genomic and expression profiling strategies are at the vanguard of current cancer biology. However, concomitant with this developing technology comes a moral responsibility to ensure that the information is used appropriately: the ethics of data collection and application are important to consider, as are efforts to ensure that these advanced technologies are used to benefit the health of everyone, not just a few.
This strong emphasis on "big science" led inevitably to questions about whether the advent of the genomic era marks the end of "small science" as we now know it. Opinions vary, but the answer really has to be no. As Sydney Brenner pointed out, information is not much use without analysis-new insights do not emerge magically from large data sets without interpretation. Instead, we should think of genomic information as a resource, and one that allows scientists to ask questions in ways that weren't possible before. Of course, broad use of this information does depend on it being accessible and user-friendly for researchers from a wide range of fields, and this is one of the main aims of publicly funded sequencing and other large-scale projects. George Poste, in particular, highlighted the strong arguments for standardization of data presentation and storage, such as the MIAME initiative for array data, to ensure that as many researchers and medical professionals as possible can use the information being accumulated in a meaningful way. Perhaps this, as much as anything, represents a challenge for scientists in the post-genomic era: making sure that the tools available are exploited to their maximum potential.
